SEC Form 4 · accession 0001127602-18-024675
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Jonas
Officer — EVP Legal Affairs,Gen. Counsel
Period of report
Aug 2, 2018
Accepted (ET)
Aug 6, 2018 · 9:46 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 2, 2018 | M | 2,000 | $32.93 | A | 20,347 | D | |
| Common Stock | Aug 2, 2018 | F | 1,221 | $80.40 | D | 19,126 | D | |
| Common Stock | Aug 2, 2018 | M | 1,560 | $44.90 | A | 20,686 | D | |
| Common Stock | Aug 2, 2018 | F | 1,106 | $80.40 | D | 19,580 | D | |
| Common Stock | Aug 2, 2018 | M | 12,000 | $51.30 | A | 31,580 | D | |
| Common Stock | Aug 2, 2018 | F | 9,133 | $80.40 | D | 22,447 | D | |
| Common StockF1 | Aug 2, 2018 | S | 4,000 | $79.73 | D | 18,447 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sars (Stock Appreciation Rights)F2 | $32.93 | Aug 2, 2018 | M | 2,000 | D | — | Jun 1, 2023 | Common Stock | 2,000 | 0 | D |
| Sars (Stock Appreciation Rights)F2 | $44.90 | Aug 2, 2018 | M | 1,560 | D | — | Jun 1, 2024 | Common Stock | 1,560 | 1,560 | D |
| Sars (Stock Appreciation Rights)F3 | $51.30 | Aug 2, 2018 | M | 12,000 | D | — | Feb 27, 2025 | Common Stock | 12,000 | 12,800 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.54 to $80.13. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
- F2The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- F3The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period.